Market Herald logo

Subscribe

Be the first with the news that moves the market
  • CBD Global (CBDN) issues first bi-Weekly report regarding management cease trade order
  • The corporation announced the delay in the filing of its audited annual financial statement for the year ended December 31, 2020
  • CBD Global applied for and was granted a management cease trade order in respect of the delayed annual filings by the Alberta Securities Commissions
  • CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle
  • CBD Global Sciences Inc. (CBDN) is trading at C$0.34 per share at 12:38 pm ET

CBD Global Sciences Inc. (CBDN) provides this initial bi-weekly default status report in accordance with national policy.

 In CBD Global’s initial default announcement dated April 14, 2021, the corporation announced the delay in the filing of its audited annual financial statements for the year ended December 31, 2020, and related management’s discussion and analysis and CEO and CFO certifications by the prescribed filing deadline.

As announced in the April 14, 2021 press release of CBD Global, it applied for and was granted a management cease trade order by the Alberta Securities Commission.

The MCTO prohibits the CEO and the CFO from trading in the corporation’s securities as long as there are filings that are outstanding under applicable securities laws.

The MCTO does not affect the ability of the general investing public to trade in the corporation’s listed common shares.

The audit of the annual financial statements is in progress and continues to expect to file the annul filings on or before June 15, 2021.

The corporation confirms that since the default notice there is no material change to the information set out in the default notice that has not been generally disclosed.

There has also been no failure by the corporation in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203.

CBD Global anticipates that its interim financial statements for the three months ended March 31, 2021, the accompanying management’s discussion and analysis and the related CEO and CFO certifications will not be filed by the prescribed filing deadline and will be filed after the Annual Filings are completed and filed.

CBD Global will continue to comply with the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly default status reports in the form of news releases for so long as it remains in default of the filing requirements set out above.

CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS and CANNAOIL.

CBD Global Sciences Inc. (CBDN) is trading at C$0.34 per share at 12:38 pm ET.

More From The Market Herald
High Tide - CEO, Raj Grover.

" High Tide’s (TSXV:HITI) Cabana Club loyalty program surpasses 500,000 members

High Tide’s (HITI) Cabana Club loyalty program has now amassed over 515,000 members.

" Potent Ventures Inc. (CSE:POT) partners with Dean’s Dairy and Specialty Foods for the Gummy Project

Potent Ventures (POT) has entered into a distribution partnership with Dean’s Dairy & Specialty Foods, to launch of the Gummy Project.
Ayr Wellness Inc. - Founder, Chairman & CEO, Jonathan Sandelman.

" Ayr Wellness’ (CSE:AYR.A) completes first sale from Phoenix facility and launches STiX products

Ayr Wellness (AYR.A) completed its first sale from its Phoenix, Arizona cultivation facility in tandem with the launch of its STiX Pre-Roll Co.